Parkinson’s Disease Therapeutics Market by Drug Class (Levodopa Combination, Dopamine Agonists, Monoamine Oxidase B (MAO-B) Inhibitors, Anticholinergic Drugs, Catechol-O-Methyltransferase (COMT) Inhibitors and Others), by Route of Adminstration (Oral, Transdermal, Subcutaneous, and Intestinal Infusion) and by Distribution Channel for Hospital Pharmacy, Retail Pharmacy and Online Sales: Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2023

Global parkinson’s disease therapeutics market expected to generate revenue of around USD 4.31 billion by end of 2023, growing at a CAGR of around 10.6% between 2017 and 2023. Parkinson’s disease is a progressive movement disorder caused when dopamine-producing nerve cells function irregularly.

Request Brochure Request Discount

11-May-2018 | Number of pages: 110 | Report Code: ZMR-2858 | Report Format : | Status : Published


The report covers forecast and analysis for the Parkinson’s disease therapeutics market on a global and regional level. The study provides historic data of 2017 along with a forecast from 2018 to 2023 based revenue (USD Billion). The study includes drivers and restraints for the Parkinson’s disease therapeutics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Parkinson’s disease therapeutics market on a global level.

In order to give the users of this report a comprehensive view on the Parkinson’s disease therapeutics market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein drug class segment, route of administration segment and distribution channel segment is benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, research & development, technology and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, the product portfolio of various companies according to the region.

Global Parkinson’s Disease Therapeutics Market

The study provides a decisive view on the Parkinson’s disease therapeutics market by segmenting the market based on drug class, route of administration, distribution channel, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2017 to 2023. Based on drug class the market is segmented into levodopa combination, dopamine agonists, monoamine oxidase B (MAO-B) inhibitors, anticholinergic drugs, catechol-o-methyltransferase (COMT) inhibitors and others. Based on rote of administration the market is segmented into the oral, transdermal, subcutaneous, and intestinal infusion. Based on distribution channel the market is segmented into hospital pharmacy, retail pharmacy, and online sales. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and the Middle East & Africa with its further bifurcation into major countries. This segmentation includes demand for Parkinson’s disease therapeutics market based on individual drug class, and distribution channel in all the regions and countries.

The report also includes detailed profiles of end players such as Novartis AG, F. Hoffmann-La Roche AG, AbbVie Inc., Teva Pharmaceutical Industries Ltd., UCB, Inc., STADA Arzneimittel AG, GlaxoSmithKline plc, Valeant Pharmaceuticals International, Inc., Merck & Co., Inc., Impax Laboratories, Inc., and Others.

This report segments the global Parkinson’s disease therapeutics market as follows:

Global Parkinson’s Disease Therapeutics Market: Drug Class Segment Analysis

  • Levodopa Combination
  • Dopamine Agonists
  • Monoamine Oxidase B (Mao-B) Inhibitors
  • Anticholinergic Drugs
  • Catechol-O-Methyltransferase (Comt) Inhibitors
  • Others

Global Parkinson’s Disease Therapeutics Market: Route of Administration Segment Analysis

  • Oral
  • Transdermal
  • Subcutaneous
  • Intestinal Infusion

Global Parkinson’s Disease Therapeutics Market: Distribution Channel Segment Analysis

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Sales

Global Parkinson’s Disease Therapeutics Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa
Your personal details are safe and secured with us. Privacy Policy SSL site seal - click to verify

Related Reports

Healthcare Cybersecurity Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2018–2026

Price : $ 3599.00 | Report Code: ZMR-2930 | Report Format:

Global Healthcare Cybersecurity Market: Overview Increasing incidents of hacking and other forms of cyber crimes have increased the need for cybersecurity in the healthcare sector. The healthcare organizations are increasingly adopting the cybersecurity solutions for keeping the cybercriminals a...Read More

Cardiovascular Information System (CVIS) Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts, 2018–2026

Price : $ 3599.00 | Report Code: ZMR-2928 | Report Format:

Global Cardiovascular Information System Market: Overview The growing issues associated with the cardiovascular care that comprise the huge data retrievals, managing the huge volumes of data and the maintenance of this vast patient information has created the need for the upgraded systems in the...Read More

Elder Care Services Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts, 2018–2024

Price : $ 3599.00 | Report Code: ZMR-2907 | Report Format:

Global Elder Care Services Market: Overview The elderly population is defined as people in the age of 65 years or older. Early elderly people comprise of the age range 65-74 years old. Late elderly people comprise of 75 years of age and above. Elder care services are the services needed by the o...Read More

In Vitro Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2875 | Report Format:

Global In Vitro Diagnostics Market: Overview In vitro diagnostic is basically utilized to detect various kinds of diseases and infection by taking the sample from the human body to treat its infection and diseases. These IVD products are mainly the reagents, instruments, or any system utilized f...Read More

Plastic Surgery Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2018–2024

Price : $ 3599.00 | Report Code: ZMR-2868 | Report Format:

Global Plastic Surgery Market: Overview Plastic surgery is a branch of cosmetic surgery concerned with the repair of deformities, the process of reconstructing by transfer of tissue, enhancement of aesthetic appearance. It can be performed on any part of the body. The global plastic surgery mark...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.